MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health threats, experts say.

A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, raising the risk of life-threatening sepsis, new research reveals.

Zein became aware of alcohol’s impact on COPD a few years ago. In a paper published in 2021, Zein and colleagues found that ...

University of Manchester biologists have for the first time started to unpick the long-term biological changes associated ...

Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...

Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...

The number of people diagnosed with tuberculosis worldwide rose again last year, eclipsing 2023's record total. About 8.3 ...

Veteran actor Prem Chopra, who was admitted to Mumbai’s Lilavati Hospital with chest congestion and breathing issues, has now ...